Article
Development of a potency assay for CD34+ cell-based therapy for post-acute myocardial infarction
2023-05-15
Abstract excerpt
<h4>Background: </h4> Acute myocardial infarction (AMI) results from obstruction of a coronary artery and affects around 126 million individuals globally. We have shown in a small pilot study that intracardiac delivery of autologous CD34 + cells after myocardial infarction is safe and leads to long term improvement. The improvement was such that three patients initially recommended for early heart transplantation...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 15100f13-5c8c-5b4e-a036-cca8ef584e9c
- DOI
- 10.21203/rs.3.rs-2864777/v1
